Terpenes as bacterial efflux pump inhibitors: A systematic review
- PMID: 36313340
- PMCID: PMC9606600
- DOI: 10.3389/fphar.2022.953982
Terpenes as bacterial efflux pump inhibitors: A systematic review
Abstract
Managing antibiotic resistance is a significant challenge in modern pharmacotherapy. While molecular analyses have identified efflux pump expression as an essential mechanism underlying multidrug resistance, the targeted drug development has occurred slower. Thus, considering the verification that terpenes can enhance the activity of antibiotics against resistant bacteria, the present study gathered evidence pointing to these natural compounds as bacterial efflux pump inhibitors. A systematic search for manuscripts published between January 2007 and January 2022 was carried out using the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) protocol and the following search terms: "Terpene"; AND "Efflux pump"; and "Bacteria." From a total of 101 articles found in the initial search, 41 were included in this review. Seventy-five different terpenes, 63 bacterial strains, and 22 different efflux pumps were reported, with carvacrol, Staphylococcus aureus SA-1199B, and NorA appearing most frequently mentioned terpene, bacterial strain, and efflux pump (EP), respectively. The Chi-Squared analysis indicated that terpenes are significantly effective EP inhibitors in Gram-positive and Gram-negative strains, with the inhibitory frequency significantly higher in Gram-positive strains. The results of the present review suggest that terpenes are significant efflux pump inhibitors and, as such, can be used in drug development targeting the combat of antibacterial resistance.
Keywords: antibiotic resistance; efflux pumps; natural products; systematic review; terpenes.
Copyright © 2022 Dias, Miranda, Bessa, Araújo, Freitas, Almeida, Paulo, Neto, Coutinho and Ribeiro-Filho.
Conflict of interest statement
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Figures




Similar articles
-
Effect of Carvacrol and Thymol on NorA efflux pump inhibition in multidrug-resistant (MDR) Staphylococcus aureus strains.J Bioenerg Biomembr. 2021 Aug;53(4):489-498. doi: 10.1007/s10863-021-09906-3. Epub 2021 Jun 22. J Bioenerg Biomembr. 2021. PMID: 34159523
-
In vitro and in silico inhibitory effects of synthetic and natural eugenol derivatives against the NorA efflux pump in Staphylococcus aureus.Food Chem. 2021 Feb 1;337:127776. doi: 10.1016/j.foodchem.2020.127776. Epub 2020 Aug 5. Food Chem. 2021. PMID: 32777574
-
Antibacterial and Inhibitory Activity of Nora and Mepa Efflux Pumps of Estragole Complexed to β-Cyclodextrin (ES/β-CD) In Vitro Against Staphylococcus aureus Bacteria, Molecular Docking and MPO-Based Pharmacokinetics Prediction.Pharmaceutics. 2024 Nov 18;16(11):1469. doi: 10.3390/pharmaceutics16111469. Pharmaceutics. 2024. PMID: 39598592 Free PMC article.
-
An Update on Staphylococcus aureus NorA Efflux Pump Inhibitors.Curr Top Med Chem. 2020;20(24):2168-2185. doi: 10.2174/1568026620666200704135837. Curr Top Med Chem. 2020. PMID: 32621719 Review.
-
Efflux Pump Inhibitors: A Novel Approach to Combat Efflux-Mediated Drug Resistance in Bacteria.Curr Drug Targets. 2016;17(6):702-19. doi: 10.2174/1389450116666151001103948. Curr Drug Targets. 2016. PMID: 26424403 Review.
Cited by
-
Mediterranean Plants with Antimicrobial Activity against Staphylococcus aureus, a Meta-Analysis for Green Veterinary Pharmacology Applications.Microorganisms. 2023 Sep 9;11(9):2264. doi: 10.3390/microorganisms11092264. Microorganisms. 2023. PMID: 37764109 Free PMC article.
-
Analysis of the Antibiotic-Potentiating Activity, Absorption, Distribution, Metabolism, and Excretion (ADME) and the Molecular Docking Properties of Phytol Against Multi-Drug-Resistant (MDR) Strains.Antibiotics (Basel). 2024 Dec 4;13(12):1171. doi: 10.3390/antibiotics13121171. Antibiotics (Basel). 2024. PMID: 39766561 Free PMC article.
-
The Dual Role of the Medicinal Mushroom Fomitopsis pinicola in Inhibiting Biofilm and Reducing Antibiotic Resistance of Methicillin-Resistant Staphylococcus aureus.Food Sci Nutr. 2025 May 27;13(6):e70355. doi: 10.1002/fsn3.70355. eCollection 2025 Jun. Food Sci Nutr. 2025. PMID: 40438095 Free PMC article.
-
Antimicrobial Metabolites of Caucasian Medicinal Plants as Alternatives to Antibiotics.Antibiotics (Basel). 2024 May 24;13(6):487. doi: 10.3390/antibiotics13060487. Antibiotics (Basel). 2024. PMID: 38927153 Free PMC article. Review.
-
Synergistic mechanism of Phyllanthus emblica extract and tetracycline against multidrug-resistant Acinetobacter baumannii.Narra J. 2025 Apr;5(1):e1939. doi: 10.52225/narra.v5i1.1939. Epub 2025 Feb 14. Narra J. 2025. PMID: 40352204 Free PMC article.
References
-
- Almeida R., Freitas P., Araújo A., Alencar Menezes I., Santos E., Tintino S., et al. (2020). GC-MS profile and enhancement of antibiotic activity by the essential oil of Ocotea odorífera and safrole: Inhibition of Staphylococcus aureus efflux pumps. Antibiotics 9, 247. 10.3390/antibiotics9050247 - DOI - PMC - PubMed
-
- Araújo A., Freitas P., Rodrigues dos Santos Barbosa C., Muniz D., Rocha J., Albuquerque da Silva A., et al. (2020). GC-MS-FID characterization and antibacterial activity of the Mikania cordifolia essential oil and limonene against MDR strains. Food Chem. Toxicol. 136, 111023. 10.1016/j.fct.2019.111023 - DOI - PubMed
Publication types
LinkOut - more resources
Full Text Sources
Molecular Biology Databases